Across the Atlantic, scientists are also making use of open access journals. In Canada, the national medical association started publishing a totally new, fully ‘open’ journal in January.
If you have a look at the title of the new Canadian Medical Association Journal, CMAJ Open, the scope of this online publication is obvious. Its editor, the Canadian Medical Association, already publishes several high-quality journals. With CMAJ Open, it goes one step further.
CMAJ Open is publishing high-quality, peer-reviewed medical research papers without the need for authors to demonstrate high impact, indicates the association. The journal posts new content online as soon as it is ready. And, of course, all content will be available at no charge to readers from the publication date.
But the ‘open’ idea behind this initiative is not strictly limited to the availability of the online media. The new journal is also ‘open’ to medical and healthcare research articles, as well as those from allied healthcare professions.
The journal claims it is also open to all types of research papers. It will consider papers with a wide variety of methodologies, including randomised controlled trials, systematic reviews, meta-analyses, case-control studies, cohort studies, surveys and qualitative research. Protocols and pilot studies are also welcome.
Finally, it will also be ‘open’ with regard to the process of accepting manuscripts, and decisions and comments from peer reviewers.
CMAJ Open is committed to an open peer-review system in which reviewer comments, author responses and previous versions are available along with the final published version. This will provide a manuscript history for readers and serve as a resource for future authors.
When, as a 16-year-old, Adam Noble began measuring nanosilver pollution in his local river, he could hardly have foreseen that it would make him CEO of a 40-strong company before his 24th birthday.
Changing the way science is done in Europe is the first job in setting up the European open science cloud, a huge shared data repository that will enable data from all publicly-funded research to be freely accessible, according to Dr Juan Bicarregui from the Science and Technology Facilities Council, UK.
The big data explosion, which allows scientists to analyse factors such as people’s lifestyles, genes and medical records to develop personalised treatments for conditions, has so far mostly benefitted rare diseases with simple causes. But now, complex problems such as cardiovascular disease and dementia are getting the big data treatment.
An analysis of a newly cleaned-up dataset tracking Europe’s air pollution has revealed that nitrogen dioxide levels are on a steeper downward trend than previously thought, according to Dr Folkert Boersma from the Royal Netherlands Meteorological Institute, who says that ensuring the quality of Earth observation data can reveal new insights into climate change.
Heart health and dementia care could be improved with algorithms.
Quality-checking satellite data can reveal new insights.
Co-author of Stephen Hawking's final paper talks about how their work goes beyond Einstein.